Bill

Bill > A07142


NY A07142

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.


summary

Introduced
03/20/2025
In Committee
03/20/2025
Crossed Over
Passed
Dead

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT to amend the insurance law and the public health law, in relation to requiring certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale

AI Summary

This bill requires health insurance issuers (including insurers, corporations, and organizations) in New York to pass along at least 85% of prescription drug rebates to patients at the point of sale, effectively reducing the amount patients pay for medications. The bill defines key terms like "rebate" and "price protection rebate", which include various negotiated price concessions from drug manufacturers or pharmacies that reduce the insurance company's costs. Insurance companies must calculate a patient's out-of-pocket costs using a price that reflects these rebates, and they are required to submit an annual certification to the state superintendent confirming their compliance. The bill also includes strict confidentiality provisions that prevent insurers from publicly revealing specific details about their rebate arrangements, protecting the financial and competitive interests of manufacturers and pharmacies. These requirements will apply to all health insurance contracts issued, renewed, or amended on or after January 1, 2025, with the goal of making prescription medications more affordable for patients by directly applying negotiated discounts at the time of purchase.

Committee Categories

Business and Industry

Sponsors (15)

Last Action

referred to insurance (on 03/20/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...